SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-040140
Filing Date
2022-03-30
Accepted
2022-03-30 16:27:59
Documents
13
Period of Report
2022-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210807d1_8k.htm   iXBRL 8-K 33782
2 EXHIBIT 10.1 tm2210807d1_ex10-1.htm EX-10.1 67252
  Complete submission text file 0001104659-22-040140.txt   291594

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrna-20220324.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20220324_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20220324_pre.xml EX-101.PRE 22603
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2210807d1_8k_htm.xml XML 3697
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 22786829
SIC: 2834 Pharmaceutical Preparations